CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-19 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion 10b5-1 | +55,400 | $30.46 | $1.7M | 97,295 |
| 2026-11-19 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion 10b5-1 | +45,700 | $26.43 | $1.2M | 142,995 |
| 2026-11-19 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −90,299 | $145.06 | $13.1M | 52,696 |
| 2026-11-19 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −8,539 | $146.76 | $1.3M | 44,157 |
| 2026-11-19 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −2,262 | $147.50 | $334K | 41,895 |
| 2026-11-19 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −55,400 | 0 | ||
| 2026-11-19 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −45,700 | 0 | ||
| 2026-10-19 | Hudson Paul Director | Grant or award | +6,139 | 6,139 | ||
| 2026-10-19 | Koppikar Utpal Director | Grant or award | +6,139 | 6,139 | ||
| 2026-09-09 | Brennan David R Director | Sale | −25,000 | $124.00 | $3.1M | 39,238 |
| 2026-08-17 | SHAROKY MELVIN MD Director | Sale | −5,000 | $127.53 | $638K | 0 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Exercise or conversion | +82,280 | $13.67 | $1.1M | 181,024 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Exercise or conversion | +76,600 | $17.16 | $1.3M | 257,624 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Exercise or conversion | +80,970 | $30.46 | $2.5M | 338,594 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Sale | −239,850 | $133.27 | $32.0M | 98,744 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −82,280 | 0 | ||
| 2026-08-10 | Adsett Roger Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −76,600 | 0 | ||
| 2026-08-10 | Adsett Roger Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −80,970 | 0 | ||
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion 10b5-1 | +18,278 | $18.95 | $346K | 78,764 |
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion 10b5-1 | +8,895 | $25.83 | $230K | 87,659 |
Page 1 of 54 · 1,061 trades